We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brazil’s Health Regulator Freezes Sinovac's Vaccine Trial, Citing Safety Incident
Brazil’s Health Regulator Freezes Sinovac's Vaccine Trial, Citing Safety Incident
Brazil’s National Agency for Sanitary Surveillance (ANVISA) has suspended Beijing, China-based Sinovac’s phase 3 trial of its COVID-19 vaccine, CoronaVac, halting the study Tuesday to evaluate a serious adverse event that occurred.